Document Detail


Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravis.
MedLine Citation:
PMID:  2148662     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The complement C3b/C4b receptor (CR1) expression on erythrocytes (E) (ECR1) from patients with myasthenia gravis (MG) and from blood donors was measured using haemadsorption and indirect hemagglutination techniques. The ECR1 expression in patients with MG appeared to be normal. This was also true for the subgroup of MG patients with additional autoimmune diseases. No correlation between ECR1 expression and severity of myasthenic symptoms was demonstrated.
Authors:
C A Vedeler; N E Gilhus; R Matre
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta neurologica Scandinavica     Volume:  82     ISSN:  0001-6314     ISO Abbreviation:  Acta Neurol. Scand.     Publication Date:  1990 Oct 
Date Detail:
Created Date:  1991-02-21     Completed Date:  1991-02-21     Revised Date:  2006-08-16    
Medline Journal Info:
Nlm Unique ID:  0370336     Medline TA:  Acta Neurol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  259-62     Citation Subset:  IM    
Affiliation:
Department of Neurology, University of Bergen, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Autoimmune Diseases / immunology
Carrier Proteins / immunology*
Complement Inactivator Proteins*
Erythrocytes / immunology*
Female
Glycoproteins*
Hemadsorption / physiology
Hemagglutination Inhibition Tests
Humans
Male
Middle Aged
Myasthenia Gravis / diagnosis,  immunology*
Receptors, Complement / immunology*
Receptors, Complement 3b
Chemical
Reg. No./Substance:
0/Carrier Proteins; 0/Complement Inactivator Proteins; 0/Glycoproteins; 0/Receptors, Complement; 0/Receptors, Complement 3b

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment strategy and results in large covered and perforated omphaloceles and gastroschisis in new...
Next Document:  Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia a...